Stay updated on Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page.

Latest updates to the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page
- Check6 days agoChange DetectedThe history now includes Revision: v3.4.3 and removes Revision: v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page shows a new Revision: v3.4.2 and removes the prior operating-status notice (Revision: v3.4.1).SummaryDifference0.5%

- Check42 days agoChange DetectedNotice about government funding lapse and NIH Clinical Center status is now shown, and the page revision has been updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check48 days agoChange DetectedThe changes are UI/UX updates (glossary toggle, color-coded change highlights, and revision notes) with no impact on actual study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check62 days agoChange DetectedA new revision label v3.3.4 was added and the previous v3.3.3 label removed in the page's Revision history; the main study details and history entries remain unchanged.SummaryDifference0.1%

- Check77 days agoChange DetectedVersion 33 adds a new 'Study Status' entry to the Record History (dated 2025-12-23), replacing the prior 2025-11-19 entry.SummaryDifference0.3%

Stay in the know with updates to Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Orforglipron vs Insulin Glargine in Type 2 Diabetes Clinical Trial page.